cognitive cybersecurity intelligence

News and Analysis

Search

The risks of direct-to-consumer pharmaceutical advertising and Big Pharma

The risks of direct-to-consumer pharmaceutical advertising and Big Pharma

In 2002, prescribing risperidone meant fighting through layers of resistance. I had to argue with formulary doctors, armed with a special copy of the New England Journal of Medicine article where my own name was highlighted, just to gain permission. That was the level of scrutiny these drugs once demanded. The article itself was not
Read more…
The risks of direct-to-consumer pharmaceutical advertising and Big Pharma originally appeared in KevinMD.com.

Source: kevinmd.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts